MoneyWorks4Me

Hikal - Quaterly Results

14 May 2025 Evaluate
A fair growth of 7.45% in the revenue at Rs. 5524.00 millions was reported in the March 2025 quarter as compared to Rs. 5141.00 millions during year-ago period.A good growth in profit of 48.82% reported to Rs. 503.00  millions over Rs. 338.00 millions of corresponding previous quarter.Operating profit for the quarter ended March 2025 rose to 1240.00 millions as compared to 948.00 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5524.00 5141.00 7.45 18598.00 17846.00 4.21 18598.00 17846.00 4.21
Other Income 5.00 5.00 0.00 50.00 25.00 100.00 50.00 25.00 100.00
PBIDT 1240.00 948.00 30.80 3335.00 2694.00 23.79 3335.00 2694.00 23.79
Interest 179.00 153.00 16.99 752.00 564.00 33.33 752.00 564.00 33.33
PBDT 1061.00 795.00 33.46 2583.00 2130.00 21.27 2583.00 2130.00 21.27
Depreciation 377.00 323.00 16.72 1344.00 1176.00 14.29 1344.00 1176.00 14.29
PBT 684.00 472.00 44.92 1239.00 954.00 29.87 1239.00 954.00 29.87
TAX 181.00 134.00 35.07 330.00 259.00 27.41 330.00 259.00 27.41
Deferred Tax 8.00 -26.00 -130.77 30.00 -25.00 -220.00 30.00 -25.00 -220.00
PAT 503.00 338.00 48.82 909.00 695.00 30.79 909.00 695.00 30.79
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 22.45 18.44 21.73 17.93 15.10 18.79 17.93 15.10 18.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..